ClinicalTrials.gg
RecruitingNCT07652645REFRESHUpdated Jun 17, 2026

Hybrid Dialectical Behavior Therapy for Veterans to Further Reduce Emotion Regulation Problems and Trauma Symptoms

An interventional study of Hybrid dialectical behavior therapy in PTSD, Emotion Regulation Disorders and Substance Abuse, sponsored by Arkin. Recruiting at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-17.

Sponsored by Arkin · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 31 studies in Stress Disorders, Post-Traumatic with a site in Netherlands — 13 open to participants now, 14 under way, none of them phase 3. Stress Disorders, Post-Traumatic · Netherlands.

Planned enrollment
21st of 26
24 · median 62
Started
2026
with 1 other
No phase
20 of 31
8 open now
Primary completion
2028-09
later than 11 of 13 live
Registered
29th of 31
by date
Lead sponsor
4 of 31
Arkin

Among the 31 studies in Stress Disorders, Post-Traumatic with a site in Netherlands, this one is the 21st largest by planned enrollment of the 26 interventional ones that give a count, is one of 2 that started in 2026, is one of 20 with no phase, reaches primary completion later than 11 of the 13 other live ones, and was the 29th registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

13 of the 31 studies in Stress Disorders, Post-Traumatic with a site in Netherlands are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies in Stress Disorders, Post-Traumatic with a site in Netherlands, or all of them as a file.
02

Study summary

Around 10% of post-active veterans experience post-traumatic stress disorder (PTSD) many years post-mission. PTSD in veterans is frequently associated with challenges in emotion regulation, aggression, suicidality, and financial and psychosocial stress. In 2018, a 12-week clinical treatment programme, the Veterans Intensive Treatment Unit (VIBU), was developed for veterans experiencing these psychiatric symptoms, for whom conventional treatments had proven ineffective. The VIBU provides patients with trauma-focused and dialectical behaviour therapy (DBT). A recent study revealed that the VIBU was effective in reducing psychiatric symptoms. However, a recurrence of symptoms was observed in patients a few months after discharge. Consequently, an aftercare programme consisting of hybrid DBT is offered to consolidate and repeat the DBT skills and apply them in daily life.

03

Conditions studied

  • PTSD
  • Emotion Regulation Disorders
  • Substance Abuse

Keywords

  • Emotional dysregulation
  • PTSD
  • DBT
  • Hybrid DBT
  • Veterans
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult veteran (18 years or older), treated at Sinai Center, with knowledge of DBT
  • Primairy diagnosis of PTSD, determined with CAPS-5, resulting from war-related traumas
  • Stable for four weeks on their medication (type and doses)
  • Able to to do online homework assignments and communicate with their therapist via an eHealth platform
  • Dutch speaking

Exclusion criteria

Exclusion Criteria:

  • Chronic psychosis (psychotic features as comorbidity from PTSD is allowed) or bipolar disorder type 1
  • IQ below 80 or cognitive disorders
  • Severe self-harming behaviour, such as auto-mutilation or suicidal ideations as main problem
  • Following day treatments or other intensive treatment for residual symptoms
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Hybrid DBT

    All participants will follow the same hybrid DBT program (i.e., group sessions, individual sessions and online homework assignments). Randomization will determine the length of the waiting period between baseline and start of the intervention (i.e., hybrid DBT).

    Behavioral: Hybrid dialectical behavior therapy

Interventions

  • BehavioralHybrid dialectical behavior therapy

    Hybrid DBT will be provided to veterans who have followed a 3-month inpatient DBT treatment. The hybrid DBT will include face-to-face skill groups, online individual sessions and online homework assignements.

    Also known as: DBT, Dialectical behavior therapy

06

What researchers measure

Primary outcomes

  1. PTSD Checklist for the DSM-5 (PCL-5)

    One of the two main outcomes of this study is PTSD symptom score. The self-report questionnaire contains 20 questions with answer options ranging from '0 = Not at all' to '4 = Extremely', resulting in a score between 0-80. A higher score indicates more likelyhood of having PTSD.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  2. Difficulties in Emotion Regulation Scale Short Form (DERS-SF)

    One of the two main outcomes of this study is emotion dysregulation severity. The self-report questionnaire contains 18 questions with answer options from '1 = Almost never' to '5 = Almost always', resulting in a score between 18-90. A higher score indicates more difficulties with regulation emotions.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

Secondary outcomes

  1. REFRESH - monitoring

    Weekly short questionnaire (i.e., 10 questions) specifically tailored to this population to monitore PTSD, emotion regulation, substance use and DBT skills. Answer options range from '1 = Totally disagree' to '10 = Totally agree', resulting in a score between 10-100. A higher score means a worse outcome.

    Time frame: From enrollment to (favourably) the end of the follow-up period (between 12-17 months)

Other outcomes

  1. Outcome Questionnaire (OQ-30.2)

    This self-report questionnaire gives an indication of overall psychiatric symptoms and entails 30 items. Answers options go from '0 = almost never' to '4 = almost alywas'. The score ranges between 0-120, with a higher score indicating a worse outcome.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  2. Alcohol Use Disorders Identification Test (AUDIT)

    This self-report questionnaire contains 10 items with answer options from '0 = never' to '4 = high usage', resulting in a score between 0-40. A higher score indicates having alcohol problems.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  3. Drug Use Disorders Identification Test (DUDIT)

    This self-report questionnaire contains 11 items with answer options from '0 = never' to '4 = high usage', resulting in a score between 0-40. A higher score indicates having drug problems.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  4. Individual Recovery Outcome Counter (i-ROC)

    This questionnaires measures wellbeing outcomes. This self-report questionnaire of 12 items uses answer options from '1 = Never' to '6 = Always', resulting in a score ranging between 12-72. A higher score indicates a better outcome.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  5. General Self-Efficacy Scale (GSES)

    This questionnaire measures self-efficacy. This self-report questionnaire of 10 items, with answer options from '1 = Not at all true' to '4 = Exactly true', with scores ranging from 10-40. A higher score indicates more self-efficacy.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  6. Dialectical behavioral therapy skills (DBT-skills)

    This questionnaire asks participants about their use of DBT skills. This self-report questionnaire of 17 items has answer options from '1 = never' to '5 = often', giving a score rangen between 17-85. A higher score indicates a positive outcome.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  7. Level of Personality Functioning Scale (LPFS 2.0)

    This questionnaire measures the level of personality functioning. This self-report questionnaire contains 12 items, with answers ranging from '1 = not often true' to '4 = often true', resulting in a score between 12-48. A higher score indicates a worse outcome.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  8. Inventarisatielijst Sociale Betrokkenheid (ISB)

    This questionnaire is about social wellbeing. This self-report questions contains 11 items, with results from '1 = almost never' to '4 = almost always', resulting in a score between 11-44. A higher score indicates a positive outcome.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  9. Aggression questionnaire (AGQ)

    This questionnaire measures different forms of aggression. This self-report questionnaire contains 29 items, with answer from '1 = Extremely uncharacteristic' to '5 = Extremely characteristic', resulting in a score between 29-145. A higher score indicates a worse outcome.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  10. Suicidal Ideation Attributes Scale (SIDAS)

    This questionnaire measures suicidal ideation. This self-report questionnaire contains 5 items, with answer from '0 = Not at all' to '10 = Completely', resulting in a score between 0-50. A higher score indicates a higher level of suicidal ideation.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  11. Non-Suicidal Self-Injury Assement Tool screener (NSSI-AT screener)

    This questionnaire measures self-injurious behavior. This self-report questionnaire contains 7 items asking about the frequency and severity of self-injurious behaviour. There is no scoring.

    Time frame: From the baseline to the end of the follow-up period (between 12-17 months)

  12. Childhood Trauma Questionnaire (CTQ)

    This questionnaire assess childhood maltreatment. This self-report questionnaire contains 28 items, with answers from '1 = Never true' to '5 = Very often true', resulting in a score between 28-140. A higher score indicate a worse outcome.

    Time frame: At baseline

07

Study locations

1 of 1 sites recruiting
  • Sinai Center
    Amstelveen, North Holland 1186 AM, Netherlands
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Very sensitive personal information.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Sep 2028, 27 months after the start.

Of 1,094 interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 27 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 23, 2026
First posted
Jun 17, 2026
StartActual
Jun 1, 2026
Primary completionEst.
Sep 2028
CompletionEst.
Oct 2028
Last update
Jun 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07652645
Lead sponsor
Arkin
Responsible party
Sponsor
First posted
Jun 17, 2026
Start date
Jun 1, 2026
Primary completion
Sep 2028 (estimated)
Completion
Oct 2028 (estimated)
Last update
Jun 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion